Exploration
Accueil
Racine
Exploration
Accueil

Serveur d'exploration sur la COVID chez les séniors

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Coronavirus disease 2019 associated with aggressive neurological and mental abnormalities confirmed based on cerebrospinal fluid antibodies: A case report.

Identifieur interne : 000706 ( Main/Exploration ); précédent : 000705; suivant : 000707

Coronavirus disease 2019 associated with aggressive neurological and mental abnormalities confirmed based on cerebrospinal fluid antibodies: A case report.

Auteurs : Maomao Wang [République populaire de Chine] ; Ting Li [République populaire de Chine] ; Fan Qiao [République populaire de Chine] ; Laixing Wang ; Chunlin Li [République populaire de Chine] ; Yanping Gong [République populaire de Chine]

Source :

RBID : pubmed:32898993

Descripteurs français

English descriptors

Abstract

INTRODUCTION

Coronavirus disease (COVID-19) is spreading worldwide. The reported possible neurological symptoms are varied and range from subtle neurologic deficits to unconsciousness. Knowledge regarding the detection, diagnosis, treatment, and follow-up of COVID-19-associated neurological damage is still limited. We report a case of serious neurological damage and mental abnormalities in a patient who was finally confirmed to have COVID-19 based on IgM and IgG antibodies in the cerebrospinal fluid (CSF).

PATIENT CONCERNS

A 68-year-old man had slight flu-like symptoms and transient loss of consciousness in early February. Exaggerated unconsciousness and deteriorating mental abnormalities occurred over the next month without severe respiratory symptoms. Craniocerebral computed tomography showed normal results, but antibodies against severe acute respiratory syndrome coronavirus 2 were 100 times higher in the CSF than in the serum; tests for viral ribonucleic acid showed negative results with both a nasopharyngeal swab and CSF sample.

DIAGNOSIS

COVID-19 pneumonia was diagnosed based on symptoms and positive results for IgM and IgG in the CSF.

INTERVENTIONS

Antiviral, fluid, and nutritional support were administered for 30 days before admission without obvious improvement. A further 18 days of routine antiviral therapy, immunoglobulin therapy (10 g per day for 5 days), and antipsychotic drug treatment were administered.

OUTCOMES

The patient's neurological and mental abnormalities were greatly ameliorated. He was discharged with mild irritability, slight shaking of the hands, and walking fatigue. These symptoms have persisted up to our last follow-up (May 4, 2020).

CONCLUSION

We believe this is the first case involving neural system injury in a patient who confirmed COVID-19 based on CSF antibody test results. Negative ribonucleic acid test results, strong positivity for antibodies, and high protein levels in the CSF suggest the possibility of autoimmune encephalitis secondary to COVID-19. This case highlights additional novel symptoms of COVID-19, and these data are important for the assessment and follow-up of COVID-19 patients.


DOI: 10.1097/MD.0000000000021428
PubMed: 32898993
PubMed Central: PMC7478433


Affiliations:

Links toward previous steps (curation, corpus...)

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Coronavirus disease 2019 associated with aggressive neurological and mental abnormalities confirmed based on cerebrospinal fluid antibodies: A case report.</title>
<author>
<name sortKey="Wang, Maomao" sort="Wang, Maomao" uniqKey="Wang M" first="Maomao" last="Wang">Maomao Wang</name>
<affiliation>
<nlm:affiliation>Department of Neurosurgery, Chang Hai Hospital, The Second Military Medical University, Shanghai.</nlm:affiliation>
<wicri:noCountry code="subField">Shanghai</wicri:noCountry>
</affiliation>
<affiliation wicri:level="3">
<nlm:affiliation>Huo Shen Shan Hospital, Wuhan.</nlm:affiliation>
<country>République populaire de Chine</country>
<placeName>
<settlement type="city">Wuhan</settlement>
<region type="région">Hubei</region>
</placeName>
<wicri:orgArea>Huo Shen Shan Hospital</wicri:orgArea>
</affiliation>
</author>
<author>
<name sortKey="Li, Ting" sort="Li, Ting" uniqKey="Li T" first="Ting" last="Li">Ting Li</name>
<affiliation wicri:level="3">
<nlm:affiliation>Department of Endocrinology, The Second Medical Center, The People's Liberation Army General Hospital, Beijing, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Department of Endocrinology, The Second Medical Center, The People's Liberation Army General Hospital, Beijing</wicri:regionArea>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Qiao, Fan" sort="Qiao, Fan" uniqKey="Qiao F" first="Fan" last="Qiao">Fan Qiao</name>
<affiliation>
<nlm:affiliation>Department of Neurosurgery, Chang Hai Hospital, The Second Military Medical University, Shanghai.</nlm:affiliation>
<wicri:noCountry code="subField">Shanghai</wicri:noCountry>
</affiliation>
<affiliation wicri:level="3">
<nlm:affiliation>Huo Shen Shan Hospital, Wuhan.</nlm:affiliation>
<country>République populaire de Chine</country>
<placeName>
<settlement type="city">Wuhan</settlement>
<region type="région">Hubei</region>
</placeName>
<wicri:orgArea>Huo Shen Shan Hospital</wicri:orgArea>
</affiliation>
</author>
<author>
<name sortKey="Wang, Laixing" sort="Wang, Laixing" uniqKey="Wang L" first="Laixing" last="Wang">Laixing Wang</name>
<affiliation>
<nlm:affiliation>Department of Neurosurgery, Chang Hai Hospital, The Second Military Medical University, Shanghai.</nlm:affiliation>
<wicri:noCountry code="subField">Shanghai</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Li, Chunlin" sort="Li, Chunlin" uniqKey="Li C" first="Chunlin" last="Li">Chunlin Li</name>
<affiliation wicri:level="3">
<nlm:affiliation>Department of Endocrinology, The Second Medical Center, The People's Liberation Army General Hospital, Beijing, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Department of Endocrinology, The Second Medical Center, The People's Liberation Army General Hospital, Beijing</wicri:regionArea>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Gong, Yanping" sort="Gong, Yanping" uniqKey="Gong Y" first="Yanping" last="Gong">Yanping Gong</name>
<affiliation wicri:level="3">
<nlm:affiliation>Department of Endocrinology, The Second Medical Center, The People's Liberation Army General Hospital, Beijing, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Department of Endocrinology, The Second Medical Center, The People's Liberation Army General Hospital, Beijing</wicri:regionArea>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:32898993</idno>
<idno type="pmid">32898993</idno>
<idno type="doi">10.1097/MD.0000000000021428</idno>
<idno type="pmc">PMC7478433</idno>
<idno type="wicri:Area/Main/Corpus">000311</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000311</idno>
<idno type="wicri:Area/Main/Curation">000311</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000311</idno>
<idno type="wicri:Area/Main/Exploration">000311</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Coronavirus disease 2019 associated with aggressive neurological and mental abnormalities confirmed based on cerebrospinal fluid antibodies: A case report.</title>
<author>
<name sortKey="Wang, Maomao" sort="Wang, Maomao" uniqKey="Wang M" first="Maomao" last="Wang">Maomao Wang</name>
<affiliation>
<nlm:affiliation>Department of Neurosurgery, Chang Hai Hospital, The Second Military Medical University, Shanghai.</nlm:affiliation>
<wicri:noCountry code="subField">Shanghai</wicri:noCountry>
</affiliation>
<affiliation wicri:level="3">
<nlm:affiliation>Huo Shen Shan Hospital, Wuhan.</nlm:affiliation>
<country>République populaire de Chine</country>
<placeName>
<settlement type="city">Wuhan</settlement>
<region type="région">Hubei</region>
</placeName>
<wicri:orgArea>Huo Shen Shan Hospital</wicri:orgArea>
</affiliation>
</author>
<author>
<name sortKey="Li, Ting" sort="Li, Ting" uniqKey="Li T" first="Ting" last="Li">Ting Li</name>
<affiliation wicri:level="3">
<nlm:affiliation>Department of Endocrinology, The Second Medical Center, The People's Liberation Army General Hospital, Beijing, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Department of Endocrinology, The Second Medical Center, The People's Liberation Army General Hospital, Beijing</wicri:regionArea>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Qiao, Fan" sort="Qiao, Fan" uniqKey="Qiao F" first="Fan" last="Qiao">Fan Qiao</name>
<affiliation>
<nlm:affiliation>Department of Neurosurgery, Chang Hai Hospital, The Second Military Medical University, Shanghai.</nlm:affiliation>
<wicri:noCountry code="subField">Shanghai</wicri:noCountry>
</affiliation>
<affiliation wicri:level="3">
<nlm:affiliation>Huo Shen Shan Hospital, Wuhan.</nlm:affiliation>
<country>République populaire de Chine</country>
<placeName>
<settlement type="city">Wuhan</settlement>
<region type="région">Hubei</region>
</placeName>
<wicri:orgArea>Huo Shen Shan Hospital</wicri:orgArea>
</affiliation>
</author>
<author>
<name sortKey="Wang, Laixing" sort="Wang, Laixing" uniqKey="Wang L" first="Laixing" last="Wang">Laixing Wang</name>
<affiliation>
<nlm:affiliation>Department of Neurosurgery, Chang Hai Hospital, The Second Military Medical University, Shanghai.</nlm:affiliation>
<wicri:noCountry code="subField">Shanghai</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Li, Chunlin" sort="Li, Chunlin" uniqKey="Li C" first="Chunlin" last="Li">Chunlin Li</name>
<affiliation wicri:level="3">
<nlm:affiliation>Department of Endocrinology, The Second Medical Center, The People's Liberation Army General Hospital, Beijing, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Department of Endocrinology, The Second Medical Center, The People's Liberation Army General Hospital, Beijing</wicri:regionArea>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Gong, Yanping" sort="Gong, Yanping" uniqKey="Gong Y" first="Yanping" last="Gong">Yanping Gong</name>
<affiliation wicri:level="3">
<nlm:affiliation>Department of Endocrinology, The Second Medical Center, The People's Liberation Army General Hospital, Beijing, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Department of Endocrinology, The Second Medical Center, The People's Liberation Army General Hospital, Beijing</wicri:regionArea>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Medicine</title>
<idno type="eISSN">1536-5964</idno>
<imprint>
<date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Aged (MeSH)</term>
<term>Antiviral Agents (therapeutic use)</term>
<term>Betacoronavirus (MeSH)</term>
<term>Coronavirus Infections (cerebrospinal fluid)</term>
<term>Coronavirus Infections (complications)</term>
<term>Coronavirus Infections (immunology)</term>
<term>Coronavirus Infections (therapy)</term>
<term>Humans (MeSH)</term>
<term>Immunization, Passive (methods)</term>
<term>Immunoglobulin G (cerebrospinal fluid)</term>
<term>Immunoglobulin M (cerebrospinal fluid)</term>
<term>Male (MeSH)</term>
<term>Mental Disorders (etiology)</term>
<term>Nervous System Diseases (etiology)</term>
<term>Pandemics (MeSH)</term>
<term>Pneumonia, Viral (cerebrospinal fluid)</term>
<term>Pneumonia, Viral (complications)</term>
<term>Pneumonia, Viral (immunology)</term>
<term>Pneumonia, Viral (therapy)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Antiviraux (usage thérapeutique)</term>
<term>Betacoronavirus (MeSH)</term>
<term>Humains (MeSH)</term>
<term>Immunisation passive (méthodes)</term>
<term>Immunoglobuline G ()</term>
<term>Immunoglobuline M ()</term>
<term>Infections à coronavirus ()</term>
<term>Infections à coronavirus (complications)</term>
<term>Infections à coronavirus (immunologie)</term>
<term>Infections à coronavirus (thérapie)</term>
<term>Maladies du système nerveux (étiologie)</term>
<term>Mâle (MeSH)</term>
<term>Pandémies (MeSH)</term>
<term>Pneumopathie virale ()</term>
<term>Pneumopathie virale (complications)</term>
<term>Pneumopathie virale (immunologie)</term>
<term>Pneumopathie virale (thérapie)</term>
<term>Sujet âgé (MeSH)</term>
<term>Troubles mentaux (étiologie)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="cerebrospinal fluid" xml:lang="en">
<term>Immunoglobulin G</term>
<term>Immunoglobulin M</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en">
<term>Antiviral Agents</term>
</keywords>
<keywords scheme="MESH" qualifier="cerebrospinal fluid" xml:lang="en">
<term>Coronavirus Infections</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en">
<term>Coronavirus Infections</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en">
<term>Mental Disorders</term>
<term>Nervous System Diseases</term>
</keywords>
<keywords scheme="MESH" qualifier="immunologie" xml:lang="fr">
<term>Infections à coronavirus</term>
<term>Pneumopathie virale</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en">
<term>Coronavirus Infections</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en">
<term>Immunization, Passive</term>
</keywords>
<keywords scheme="MESH" qualifier="méthodes" xml:lang="fr">
<term>Immunisation passive</term>
</keywords>
<keywords scheme="MESH" qualifier="therapy" xml:lang="en">
<term>Coronavirus Infections</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="thérapie" xml:lang="fr">
<term>Infections à coronavirus</term>
<term>Pneumopathie virale</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr">
<term>Antiviraux</term>
<term>Infections à coronavirus</term>
<term>Pneumopathie virale</term>
</keywords>
<keywords scheme="MESH" qualifier="étiologie" xml:lang="fr">
<term>Maladies du système nerveux</term>
<term>Troubles mentaux</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Aged</term>
<term>Betacoronavirus</term>
<term>Humans</term>
<term>Male</term>
<term>Pandemics</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Betacoronavirus</term>
<term>Humains</term>
<term>Immunoglobuline G</term>
<term>Immunoglobuline M</term>
<term>Infections à coronavirus</term>
<term>Mâle</term>
<term>Pandémies</term>
<term>Pneumopathie virale</term>
<term>Sujet âgé</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">
<p>
<b>INTRODUCTION</b>
</p>
<p>Coronavirus disease (COVID-19) is spreading worldwide. The reported possible neurological symptoms are varied and range from subtle neurologic deficits to unconsciousness. Knowledge regarding the detection, diagnosis, treatment, and follow-up of COVID-19-associated neurological damage is still limited. We report a case of serious neurological damage and mental abnormalities in a patient who was finally confirmed to have COVID-19 based on IgM and IgG antibodies in the cerebrospinal fluid (CSF).</p>
</div>
<div type="abstract" xml:lang="en">
<p>
<b>PATIENT CONCERNS</b>
</p>
<p>A 68-year-old man had slight flu-like symptoms and transient loss of consciousness in early February. Exaggerated unconsciousness and deteriorating mental abnormalities occurred over the next month without severe respiratory symptoms. Craniocerebral computed tomography showed normal results, but antibodies against severe acute respiratory syndrome coronavirus 2 were 100 times higher in the CSF than in the serum; tests for viral ribonucleic acid showed negative results with both a nasopharyngeal swab and CSF sample.</p>
</div>
<div type="abstract" xml:lang="en">
<p>
<b>DIAGNOSIS</b>
</p>
<p>COVID-19 pneumonia was diagnosed based on symptoms and positive results for IgM and IgG in the CSF.</p>
</div>
<div type="abstract" xml:lang="en">
<p>
<b>INTERVENTIONS</b>
</p>
<p>Antiviral, fluid, and nutritional support were administered for 30 days before admission without obvious improvement. A further 18 days of routine antiviral therapy, immunoglobulin therapy (10 g per day for 5 days), and antipsychotic drug treatment were administered.</p>
</div>
<div type="abstract" xml:lang="en">
<p>
<b>OUTCOMES</b>
</p>
<p>The patient's neurological and mental abnormalities were greatly ameliorated. He was discharged with mild irritability, slight shaking of the hands, and walking fatigue. These symptoms have persisted up to our last follow-up (May 4, 2020).</p>
</div>
<div type="abstract" xml:lang="en">
<p>
<b>CONCLUSION</b>
</p>
<p>We believe this is the first case involving neural system injury in a patient who confirmed COVID-19 based on CSF antibody test results. Negative ribonucleic acid test results, strong positivity for antibodies, and high protein levels in the CSF suggest the possibility of autoimmune encephalitis secondary to COVID-19. This case highlights additional novel symptoms of COVID-19, and these data are important for the assessment and follow-up of COVID-19 patients.</p>
</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">32898993</PMID>
<DateCompleted>
<Year>2020</Year>
<Month>09</Month>
<Day>23</Day>
</DateCompleted>
<DateRevised>
<Year>2020</Year>
<Month>10</Month>
<Day>01</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1536-5964</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>99</Volume>
<Issue>36</Issue>
<PubDate>
<Year>2020</Year>
<Month>Sep</Month>
<Day>04</Day>
</PubDate>
</JournalIssue>
<Title>Medicine</Title>
<ISOAbbreviation>Medicine (Baltimore)</ISOAbbreviation>
</Journal>
<ArticleTitle>Coronavirus disease 2019 associated with aggressive neurological and mental abnormalities confirmed based on cerebrospinal fluid antibodies: A case report.</ArticleTitle>
<Pagination>
<MedlinePgn>e21428</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1097/MD.0000000000021428</ELocationID>
<Abstract>
<AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Coronavirus disease (COVID-19) is spreading worldwide. The reported possible neurological symptoms are varied and range from subtle neurologic deficits to unconsciousness. Knowledge regarding the detection, diagnosis, treatment, and follow-up of COVID-19-associated neurological damage is still limited. We report a case of serious neurological damage and mental abnormalities in a patient who was finally confirmed to have COVID-19 based on IgM and IgG antibodies in the cerebrospinal fluid (CSF).</AbstractText>
<AbstractText Label="PATIENT CONCERNS" NlmCategory="UNASSIGNED">A 68-year-old man had slight flu-like symptoms and transient loss of consciousness in early February. Exaggerated unconsciousness and deteriorating mental abnormalities occurred over the next month without severe respiratory symptoms. Craniocerebral computed tomography showed normal results, but antibodies against severe acute respiratory syndrome coronavirus 2 were 100 times higher in the CSF than in the serum; tests for viral ribonucleic acid showed negative results with both a nasopharyngeal swab and CSF sample.</AbstractText>
<AbstractText Label="DIAGNOSIS" NlmCategory="METHODS">COVID-19 pneumonia was diagnosed based on symptoms and positive results for IgM and IgG in the CSF.</AbstractText>
<AbstractText Label="INTERVENTIONS" NlmCategory="METHODS">Antiviral, fluid, and nutritional support were administered for 30 days before admission without obvious improvement. A further 18 days of routine antiviral therapy, immunoglobulin therapy (10 g per day for 5 days), and antipsychotic drug treatment were administered.</AbstractText>
<AbstractText Label="OUTCOMES" NlmCategory="RESULTS">The patient's neurological and mental abnormalities were greatly ameliorated. He was discharged with mild irritability, slight shaking of the hands, and walking fatigue. These symptoms have persisted up to our last follow-up (May 4, 2020).</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">We believe this is the first case involving neural system injury in a patient who confirmed COVID-19 based on CSF antibody test results. Negative ribonucleic acid test results, strong positivity for antibodies, and high protein levels in the CSF suggest the possibility of autoimmune encephalitis secondary to COVID-19. This case highlights additional novel symptoms of COVID-19, and these data are important for the assessment and follow-up of COVID-19 patients.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Wang</LastName>
<ForeName>Maomao</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurosurgery, Chang Hai Hospital, The Second Military Medical University, Shanghai.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Huo Shen Shan Hospital, Wuhan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Li</LastName>
<ForeName>Ting</ForeName>
<Initials>T</Initials>
<AffiliationInfo>
<Affiliation>Department of Endocrinology, The Second Medical Center, The People's Liberation Army General Hospital, Beijing, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Qiao</LastName>
<ForeName>Fan</ForeName>
<Initials>F</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurosurgery, Chang Hai Hospital, The Second Military Medical University, Shanghai.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Huo Shen Shan Hospital, Wuhan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Wang</LastName>
<ForeName>Laixing</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurosurgery, Chang Hai Hospital, The Second Military Medical University, Shanghai.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Li</LastName>
<ForeName>Chunlin</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Department of Endocrinology, The Second Medical Center, The People's Liberation Army General Hospital, Beijing, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Gong</LastName>
<ForeName>Yanping</ForeName>
<Initials>Y</Initials>
<AffiliationInfo>
<Affiliation>Department of Endocrinology, The Second Medical Center, The People's Liberation Army General Hospital, Beijing, China.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D002363">Case Reports</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Medicine (Baltimore)</MedlineTA>
<NlmUniqueID>2985248R</NlmUniqueID>
<ISSNLinking>0025-7974</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D007074">Immunoglobulin G</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D007075">Immunoglobulin M</NameOfSubstance>
</Chemical>
</ChemicalList>
<SupplMeshList>
<SupplMeshName Type="Disease" UI="C000657245">COVID-19</SupplMeshName>
<SupplMeshName Type="Organism" UI="C000656484">severe acute respiratory syndrome coronavirus 2</SupplMeshName>
</SupplMeshList>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000073640" MajorTopicYN="N">Betacoronavirus</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName>
<QualifierName UI="Q000134" MajorTopicYN="N">cerebrospinal fluid</QualifierName>
<QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
<QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D007116" MajorTopicYN="N">Immunization, Passive</DescriptorName>
<QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D007074" MajorTopicYN="N">Immunoglobulin G</DescriptorName>
<QualifierName UI="Q000134" MajorTopicYN="N">cerebrospinal fluid</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D007075" MajorTopicYN="N">Immunoglobulin M</DescriptorName>
<QualifierName UI="Q000134" MajorTopicYN="N">cerebrospinal fluid</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D001523" MajorTopicYN="N">Mental Disorders</DescriptorName>
<QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D009422" MajorTopicYN="N">Nervous System Diseases</DescriptorName>
<QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D011024" MajorTopicYN="N">Pneumonia, Viral</DescriptorName>
<QualifierName UI="Q000134" MajorTopicYN="N">cerebrospinal fluid</QualifierName>
<QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
<QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="entrez">
<Year>2020</Year>
<Month>9</Month>
<Day>9</Day>
<Hour>1</Hour>
<Minute>2</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2020</Year>
<Month>9</Month>
<Day>10</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2020</Year>
<Month>9</Month>
<Day>24</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">32898993</ArticleId>
<ArticleId IdType="doi">10.1097/MD.0000000000021428</ArticleId>
<ArticleId IdType="pii">00005792-202009040-00005</ArticleId>
<ArticleId IdType="pmc">PMC7478433</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>N Engl J Med. 2020 Mar 26;382(13):1199-1207</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">31995857</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2020 Feb 20;382(8):727-733</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">31978945</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2020 Jun 4;382(23):2268-2270</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32294339</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2016 Aug 4;375(5):497-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27518687</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet Neurol. 2020 May;19(5):383-384</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32246917</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Neurol Neurosurg Psychiatry. 2020 Aug;91(8):846-848</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32354770</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Neurol Neurosurg Psychiatry. 2020 Jun;91(6):669-670</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32312873</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Can Chiropr Assoc. 2011 Mar;55(1):32-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21403780</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Neurol. 2017 Jul;13(3):227-233</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28748673</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Sci China Life Sci. 2020 Mar;63(3):457-460</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32009228</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>République populaire de Chine</li>
</country>
<region>
<li>Hubei</li>
</region>
<settlement>
<li>Pékin</li>
<li>Wuhan</li>
</settlement>
</list>
<tree>
<noCountry>
<name sortKey="Wang, Laixing" sort="Wang, Laixing" uniqKey="Wang L" first="Laixing" last="Wang">Laixing Wang</name>
</noCountry>
<country name="République populaire de Chine">
<region name="Hubei">
<name sortKey="Wang, Maomao" sort="Wang, Maomao" uniqKey="Wang M" first="Maomao" last="Wang">Maomao Wang</name>
</region>
<name sortKey="Gong, Yanping" sort="Gong, Yanping" uniqKey="Gong Y" first="Yanping" last="Gong">Yanping Gong</name>
<name sortKey="Li, Chunlin" sort="Li, Chunlin" uniqKey="Li C" first="Chunlin" last="Li">Chunlin Li</name>
<name sortKey="Li, Ting" sort="Li, Ting" uniqKey="Li T" first="Ting" last="Li">Ting Li</name>
<name sortKey="Qiao, Fan" sort="Qiao, Fan" uniqKey="Qiao F" first="Fan" last="Qiao">Fan Qiao</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidSeniorV1/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000706 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000706 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidSeniorV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:32898993
   |texte=   Coronavirus disease 2019 associated with aggressive neurological and mental abnormalities confirmed based on cerebrospinal fluid antibodies: A case report.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:32898993" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a CovidSeniorV1
Wicri

This area was generated with Dilib version V0.6.37.
Data generation: Thu Oct 15 09:49:45 2020. Site generation: Wed Jan 27 17:10:23 2021